Patent holdings for IPC class C07C 271/24

Total number of patents in this class: 248

10-year publication summary

25
14
18
20
19
10
10
8
10
7
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bio-Pharm Solutions Co., Ltd.
60
13
Daiichi Sankyo Company, Limited
1874
11
Reata Pharmaceuticals Holdings, LLC
48
7
Glaxosmithkline Intellectual Property (no.2) Limited
287
5
Mitsui Chemicals, Inc.
3219
5
The Trustees of Columbia University in the City of New York
3575
5
Covestro Deutschland AG
2748
5
GE Healthcare Limited
673
5
Monash University
707
5
Xwpharma Ltd.
57
5
Taisho Pharmaceutical Co., Ltd.
870
4
Saniona A/S
48
4
Novartis AG
10850
3
Bristol-myers Squibb Company
4893
3
The Regents of the University of California
19929
3
Arbutus Biopharma Corporation
177
3
BenQ Materials Corporation
157
3
Eli Lilly and Company
3844
3
Katholieke Universiteit Leuven K.u. Leuven R & D
211
3
Korea Research Institute of Chemical Technology
1390
3
Other owners 150